The effects of local anaesthesia with bupivacaine and botulinum toxin-A after thoracotomy on stress hormone levels
To investigate the effects of local and systemic analgesics on stress hormone levels, which increase after thoracotomy. Materials and methods: Sixty-three male rats were divided into 9 groups (n = 7). In the control animals, only a blood sample was taken. In the thoracotomy group, a retractor was inserted for 1 h. In the local anaesthesia group, intercostal nerve block was performed with bupivacaine or botulinum toxin-A. In the systemic analgesia group, blockade was performed with bupivacaine and diclofenac sodium was given intraperitoneally. Blood samples were taken twice 4 h and 24 h after thoracotomy. Results: At 4 h, stress hormone levels were significantly higher in all groups compared to the control (P < 0.05). In the systemic analgesia group, cortisol level was lower than in the thoracotomy group (P < 0.05), and lactate dehydrogenase level was lower than in the thoracotomy and bupivacaine groups (P < 0.05). At 24 h, all stress hormones except glucose were significantly higher in all groups compared to the control (P < 0.05). Norepinephrine level was significantly lower in the systemic analgesia group as compared with the thoracotomy group (P < 0.05). Conclusion: Our study showed that analgesic therapy alone may be insufficient to lower stress hormone levels, which increase after thoracotomy.
The effects of local anaesthesia with bupivacaine and botulinum toxin-A after thoracotomy on stress hormone levels
To investigate the effects of local and systemic analgesics on stress hormone levels, which increase after thoracotomy. Materials and methods: Sixty-three male rats were divided into 9 groups (n = 7). In the control animals, only a blood sample was taken. In the thoracotomy group, a retractor was inserted for 1 h. In the local anaesthesia group, intercostal nerve block was performed with bupivacaine or botulinum toxin-A. In the systemic analgesia group, blockade was performed with bupivacaine and diclofenac sodium was given intraperitoneally. Blood samples were taken twice 4 h and 24 h after thoracotomy. Results: At 4 h, stress hormone levels were significantly higher in all groups compared to the control (P < 0.05). In the systemic analgesia group, cortisol level was lower than in the thoracotomy group (P < 0.05), and lactate dehydrogenase level was lower than in the thoracotomy and bupivacaine groups (P < 0.05). At 24 h, all stress hormones except glucose were significantly higher in all groups compared to the control (P < 0.05). Norepinephrine level was significantly lower in the systemic analgesia group as compared with the thoracotomy group (P < 0.05). Conclusion: Our study showed that analgesic therapy alone may be insufficient to lower stress hormone levels, which increase after thoracotomy.
___
- Flatters SJL. Characterization of a model of persistent postoperative pain evoked by skin/muscle incision and retraction (SMIR). Pain 2008; 135: 119-30.
- Ju H, Feng Y, Yang B, Wang J. Comparison of epidural and intercostal nerve cryoanalgesia for post-thoracotomy pain control. Eur J Pain 2008; 12: 378-84.
- Chapman CR, Tuckett RP, Song CW. Pain and stress in a systems perspective: reciprocal neural, endocrine, and immune interactions. J Pain 2008; 9: 122-45. 4. Nara T, Saito S, Obata H, Goto F. A rat model of postthoracotomy pain: behavioural and spinal cord NK-1 receptor assessment. Reg Anesth Pain Med 2001; 48: 665-76.
- Willis B, Eubanks LM, Dickerson TJ, Janda KD. Th e strange case of the botulinum neurotoxin: using chemistry and biology to modulate the most deadly poison. Angew Chem Int Ed 2008; 47: 8360-79.
- Caleo M, Antonucci F, Restani L, Mazzocchio R. A reappraisal of the central eff ects of botulinum neurotoxin type A: by what mechanism? J Neurochemistry 2009; 109: 15-24.
- Jeynes LC, Gauci CA. Evidence for the use of botulinum toxin in the chronic pain setting- a review of the literature. World Institute of Pain 2008; 8: 269-76.
- Guide for the care and use of laboratory animals. Bethesda, MD: National Institutes of Health, 1985; Publication No. 85-23.
- Mravec B, Tillinger A, Bodnar I, Nagy GM, Palkovits M, Kvetnansky R. Th e response of plasma catecholamines in rats simultaneously exposed to immobilization and pain stimuli. Ann NY Acad Sci 2008; 1148: 196-200.
- Tacconi F, Pompeo E, Sellitri F, Mineo TC. Surgical stress hormones response is reduced aft er awake videothoracoscopy. Interactive Card Th or Surg 2010; 10: 666-71.
- Bouwmeester NJ, Anand KJS, Dijk MV, Hop WCJ, Boomsma F, Tibboel D. Hormonal and metabolic stress responses aft er major surgery in children aged 0-3 years: a double blind, randomized trial comparing the eff ects of continuous versus intermittent morphine. Br J Anaesth 2001; 87: 390-9.
- Buvanendran A, Kroin JS, Kerns JM, Nagalla SNK, Tuman KJ. Characterization of a new animal model for evaluation of persistent postthoracotomy pain. Anesth Analg 2004; 99: 1453- 60.
- Detterbeck FC. Effi cacy of methods of intercostal nerve blockade for pain relief aft er thoracotomy. Ann Th or Surg 2005; 80: 1550-9.
- Fibla JJ, Molins L, Mier JM, Sierra A, Vidal G. Comparative analysis of analgesic quality in the postoperative of thoracotomy: paravertebral block with bupivacaine 0.5% vs ropivacaine 0.2%. Eur J Cardio-thorac Surg 2008; 33: 430-4.
- Dabir S, Parsa T, Radpay B. Interpleural morphine vs bupivacaine for postthoracotomy pain relief. Asian Cardiovasc Th orac Ann 2008; 16: 370-4.
- Cosmo GD, Mascia A, Clemente A, Congedo E, Aceto P. Use of levobupvacaine for the treatment of postoperative pain aft er thoracotomies. Minerva Anestesiol 2005; 71: 347-51.
- Navlet GM, Garutti I, Olmedilla L, Pérez-Peña JM, San Joaquin MT, Martinez-Ragues G, et al. Paravertebral ropivacaine 0.3%, and bupivacaine 0.25%, provide similar pain relief aft er thoracotomy. J Cardiothor Vasc Anesth 2006; 20: 644-7.
- McLeod GA, Burke D. Levobupivacaine. Anaesthesia 2001; 56: 331-41.
- Durmazlar SPK, Eskioğlu F. Botulinum toxin (Fundamentals before practice): Review. Tur Klin Med J Med Sci 2009; 29: 702- 7.
- Lu DW, Lippitz J. Complications of botulinum neurotoxin. Dis Mon 2009; 55: 198-211.